Star Scientific (NASDAQ:CIGX), a maker of tobacco and technologies used to reduce its harm, reported on Tuesday the successful development of a moist snuff tobacco that has much lower levels of carcinogens than others on the market.
With only 20 parts per billion of tobacco-specific nitrosamines, recognized by scientists worldwide as one of the most powerful cancer-causing agents in its leaf and smoke, the new tobacco is 99% lower than the levels found in conventional American moist snuffs such as Copenhagen and Skoal and 90% less than levels found in current â€śsnusâ€ť products.
Moist snuff products account for the highest portion of the smokeless tobacco industry, some 73%, and have been growing at an annual rate of 4% to 7% over the past five years.
â€śWe knew we could make a snuff product that had hundreds of times lower toxin levels, since we already had pioneered this achievement with our BDL dissolvable smokeless products,â€ť said Star Scientific Chairman Paul L. Perito. â€śWe are proud of our continued leadership in innovation -- it is clear that the means are available for all tobacco companies to reduce well-established toxins in the tobacco they use in manufacturing.â€ť
Star plans on submitting an application in the first-quarter of this year for approval to market Stonewall Moist-BDL as a modified-risk tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. The Glen Allen, Va-based company believes the application would be the first of its kind for a moist-snuff tobacco product.
In June, Star submitted modified-risk applications to the Food & Drug Administration for dissolvable smokeless products. The approval process is expected to take 260 days or less after filing.